1. DeNovo RC, Bright RM. Recto-anal Disease. In: Ettinger SJ, Feldman EC (eds.) Textbook of Veterinary Internal Medicine 5th ed. St. Louis: Elsevier Saunders, 2000;1264-1266.
2. Day MJ, Weaver BM. Pathology of surgically resected tissue from 305 cases of anal furunculosis in the dog. J Small Anim Pract 1992;33: 583-589.
3. House A, Gregory SO, Catchpole B. Expression of cytokine mRNA in canine anal furunculosis lesions. Vet Rec 2003;153:354-358.
4. Mullin GE, Lazenby AJ, Harris ML, et al. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn’s disease but not ulcerative colitis. Gastroenterology 1992;102:1620-1627.
5.Tivers MS, Catchpole B, Gregory S, et al. Interleukin-2 and interferon-gamma mRNA expression in canine anal furunculosis lesions and the effects of cyclosporine therapy. Vet Immunol Immunopathol 2008;125:31-35.
6. Matthews KA, Sukhiani HR. Randomized controlled trial of cyclosporine for treatment of perianal fistulas in dogs.
J Am Vet Med Assoc 1997;211:1249-1253.
7. Boyapati R, Satsangi J, Ho GT. Pathogenesis of Crohn’s disease. F1000Pri-me Rep 2015;7:44.
8. Massey J, Short AD, Catchpole B, et al. Genetics of canine anal furunculosis. Immunogenetics 2014;66:311-324.
9. Kennedy LJ, O’Neill T, House A, et al. Risk of anal furunculosis in German Shepherd dogs is associated with the major histocompatibility complex. Tissue Antigens 2007;71:51-56.
10. Patterson AP and Campbell KL. Managing anal furunculosis in dogs. Comp Cont Educ Practicing Vet 2005;27:339-355.
11. Proverbio D, Perego R, Spada E, et al. Prevalence of adverse food reactions in 130 dogs in Italy with dermatological signs: a retrospective study. J Small Anim Pract 2010;51:370-374.
12. Jamieson PM, Simpson JW, Kirby BM, et al. Association between anal furunculosis and colitis in the dog: preliminary observations. J Small Anim Pract 2002;43:109-114.
13. Lombardi RL and Marino DJ. Long-term evaluation of canine perianal fistula disease treated with exclusive fish and potato diet and surgical excision. J Am Anim Hosp Assoc 2008;44:302-307.
14. Harkin KR, Phillips D, Wilkerson M. Evaluation of azathioprine on lesion severity and lymphocyte blastogenesis in dogs with perianal fistulas. J Am Anim Hosp Assoc 2007;43:21-26.
15. Ackermann AL, May ER, Frank LA. Use of mycophenolate mofetil to treat immune-mediated skin diseases in 14 dogs. Vet Dermatol 2017;28:195-199.
16. Guagère E, Steffan J, Olivry T. Cyclosporine A: a new drug in the field of canine dermatology. Vet Dermatol 2004;15:61-74.
17. Klein A, Deneuche A, Fayolle P, et al. Preoperative immunosuppressive therapy and surgery as a treatment for anal furunculosis. Vet Surg 2006;35:759-768.
18. Mouatt JG. Cyclosporine and ketoconazole interaction for treatment of perianal fistulas in dogs. Aust Vet J 2002;80:207-211.
19. Patricelli AJ, Hardie RJ, McAnulty JF. Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs. J Am Vet Med Assoc 2002;220:1009-1016.
20. Doust R, Griffith LK, Sullivan M. Evaluation of once-daily treatment with cyclosporine for anal furunculosis in dogs. Vet Rec 2003;152:225-229.
21. Hardie RJ, Gregory SP, Tomlin J, et al. Cyclosporine treatment of anal furunculosis in 26 dogs. J Small Anim Pract 2005;46:3-9.
22. O’Neill T, Edwards GA, Holloway S. Efficacy of combined cyclosporine A and ketoconazole treatment of anal furunculosis. J Small Anim Pract 2004;45:238-243.
23. Misseghers BS, Binnington AG, Mathews KA. Clinical observations of the treatment of canine perianal fistulas with topical tacrolimus in 10 dogs. Can Vet J 2000;41:623-627.
24. Stanley B and Hauptman J. Long-term prospective evaluation of topically applied 0.1% tacrolimus ointment for treatment of perianal sinuses in dogs. J Am Vet Med Assoc 2009;235:397-404.
25. Ferrer L, Kimbrel EA, Lam A, et al. Treatment of perianal fistulas with human embryonic stem cell-derived mesenchymal stem cells: a canine model of human fistulizing Crohn’s disease. Regen Med 2016;11:33-43.